Cancer Genomics for Personalized Medicine

Date/Time
Date(s) - 10 Nov 2011 until 10 Nov 2011
5:30 PM - 8:00 PM

Location
Scottsdale Resort Hilton


Cancer Genomics for Personalized Medicine

(an MIT Enterprise Forum Event)

Thursday, November 10, 2011

5:30 – 8:00 pm Scottsdale Resort Hilton

6333 North Scottsdale Road, Scottsdale, AZ 85250, 480-948-7750

  • At the door, $50
  • MIT EF-Phoenix Member, Affiliate, member’s family, $40
  • Exhibitor at Entrepreneur Showcase, $40 (Marketing Suggestions)
  • Annual membership fee for the MIT
    Club, including 1 ticket, $100
  • Sponsor, Volunteer, $00
  • Others,  $45

 

“For the first  time, scientists can track the precise genetic changes behind an individual
case of cancer. …it could change the way we treat the disease.”
  Technology  Review, January 2011

The Entrepreneurs’ Showcase starts at 5:30 pm where  you can meet startup teams in the diverse medical business, from diagnostics and devices to health care records.

Please enjoy networking, the light buffet and cash bar.

The Panel Discussion begins at 6:30 with a non-technical overview of the status of cancer genomics and will emphasize the entrepreneurial opportunities for personalized medicine.

Seed the session with your ideas at our Facebook page, Linkedin group, Twitter,Meetup. Send us your comments now.

Speakers

MaryAnn Guerra, MBA, is the Chief Executive Officer and co-founder of BioAccel. Ms. Guerra’s executive positions at the National Institutes of Health were Deputy Director of Management and Executive Officer at the National Cancer Institute; Executive Officer of the National Heart, Lung, and Blood  Institute; and Chief of the Technology Transfer and Intramural Management  Branch at the National Institute of Allergy and Infectious Diseases.

Ron King, Ph.D., MBA, is the Chief Science and Business Officer and a co-founder of BioAccel. Dr. King is expert in integrating science and business by creating innovative programs to transform new technologies into products and business opportunities. Dr. King helped manage the development of several technology programs associated with the Human Genome Project.

John Carpten, PhD, is Translational  Genomics Research Institute’s (Tgen) director of Integrated Cancer Genomics. He discovered mutations in the genes responsible for prostate cancer, congenital joint diseases and hyperparathyroidism jaw-tumor syndrome. He has begun to apply Next Generation Sequencing technologies to profiling tumors.

Pat Elliott is a e-Patient Advocate whose blood cancer is treated with targeted gene therapy. She was an entrepreneur and has held executive roles at HP, Intel and Motorola Healthcare. She now works with the health media companies  PatientPower and EmpowHER, and supports cancer patients by blogging, hosting  programs on patient portals, building global online patient communities, and more.
———————–

The MIT Enterprise  Forum-Phoenix is the Phoenix AZ chapter of the MIT Enterprise Forum, a global  not-for-profit organization whose goal is to foster entrepreneurship,  especially in technology sectors. It is founded by the Massachusetts  Institute of Technology and sponsored by major universities and private  enterprises around the world. Each local chapter produces events to inform  the public, build a community of supporters, facilitate business networking,  and educate and assist early stage entrepreneurs.

 

Leave a Reply